A release attributed to Aker BioMarine but in fact authored by competitor Enzymotec was incorrectly published briefly on NPI Center. The release incorrectly stated krill oil supplier Aker BioMarine was launching a direct-to-consumer product.
"This unequivocally is not true that Aker is in competition with our customers, nor would we ever (compete with them)," said Eric Anderson, vice president of sales and marketing of Aker Biomarine.
Enzymotec had previously retracted the e-mail that was incorrectly republished. "We appreciate Enzymotec’s efforts to rectify the situation," Anderson said.
New Hope Natural Media, publisher of NPI Center, regrets the error.
About Aker BioMarine
Aker BioMarine is an integrated biotechnology company dedicated to the sustainable harvesting of krill and development of krill-derived biotech products. The company supplies biomarine ingredients through an optimized value chain from raw materials to customers. Aker BioMarine's SuperbaTM Krill products are provided with 100-percent traceability from the Antarctic sea to the end user. Only Aker BioMarine's krill fishery has been awarded Marine Stewardship Council (MSC) Certification. www.akerbiomarine.com